Evidence map›Paper›PMID 30726156›Full record

ArticleJournal of neurophysiology2019

Dopamine D1 receptor activation reduces local inner retinal inhibition to light-adapted levels.

Reece E Mazade, Michael D Flood, Erika D Eggers

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurophysiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Glycine Release Is Potentiated by cAMP via EPAC2 and CaThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  8. Article
  9. Article
  10. Neurochemistry of Visual Attention.Frontiers in neuroscience · 2021
    Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Reece E MazadeDepartments of Physiology and Biomedical Engineering, University of Arizona , Tucson, Arizona.
Michael D FloodDepartments of Physiology and Biomedical Engineering, University of Arizona , Tucson, Arizona.ORCID 0000-0001-8516-9582
Erika D EggersDepartments of Physiology and Biomedical Engineering, University of Arizona , Tucson, Arizona.ORCID 0000-0003-1465-7284
University of Arizona · US

Funding

PHYSIOLOGYT32HL007249 · NHLBI · UNIVERSITY OF ARIZONA · PI Brett A Colson, JOHN P KONHILAS · 1985 to 2026
$12.5M
Retinal Neuronal Signaling in Early DiabetesR01EY026027 · NEI · UNIVERSITY OF ARIZONA · PI EGGERS, ERIKA D. · 2016 to 2024
$2.9M
GABAergic and Glycinergic Inhibition in the Inner RetinaR00EY018131 · NEI · UNIVERSITY OF ARIZONA · PI EGGERS, ERIKA D. · 2009 to 2011
$728k
NEI NIH HHS R00 EY018131NEI NIH HHS R01 EY026027NHLBI NIH HHS T32 HL007249
6 · The paper itself

Abstract

During adaptation from dim to bright environments, changes in retinal signaling are mediated, in part, by dopamine. Dopamine is released with light and can modulate retinal receptive fields, neuronal coupling, inhibitory receptors, and rod pathway inhibition. However, it is unclear how dopamine affects inner retinal inhibition to cone bipolar cells, which relay visual information from photoreceptors to ganglion cells and are important signal processing sites. We tested the hypothesis that dopamine (D)1 receptor activation is sufficient to elicit light-adapted inhibitory changes. Local light-evoked inhibition and spontaneous activity were measured from OFF cone bipolar cells in dark-adapted mouse retinas while stimulating D1 receptors, which are located on bipolar, horizontal, and inhibitory amacrine cells. The D1 agonist SKF38393 reduced local inhibitory light-evoked response magnitude and increased response transience, which mimicked changes measured with light adaptation. D1-mediated reductions in local inhibition were more pronounced for glycinergic than GABAergic inputs, comparable with light adaptation. The effects of D1 receptors on light-evoked input were similar to the effects on spontaneous input. D1 receptor activation primarily decreased glycinergic spontaneous current frequency, similar to light adaptation, suggesting mainly a presynaptic amacrine cell site of action. These results expand the role of dopamine to include signal modulation of cone bipolar cell local inhibition. In this role, D1 receptor activation, acting primarily through glycinergic amacrine cells, may be an important mechanism for the light-adapted reduction in OFF bipolar cell inhibition since the actions are similar and dopamine is released during light adaptation. NEW & NOTEWORTHY Retinal adaptation to different luminance conditions requires the adjustment of local circuits for accurate signaling of visual scenes. Understanding mechanisms behind luminance adaptation at different retinal levels is important for understanding how the retina functions in a dynamic environment. In the mouse, we show that dopamine pathways reduce inner retinal inhibition similar to increased background luminance, suggesting the two are linked and highlighting a possible mechanism for light adaptation at an early retinal processing center.

Indexed as

Adaptation, PhysiologicalContrast SensitivityNeural Inhibition2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineAmacrine CellsAnimalsDopamine Agonistsgamma-Aminobutyric AcidGlycineMaleMiceMice, Inbred C57BLReceptors, Dopamine D1Retinal Cone Photoreceptor CellsSynaptic TransmissionVision, Ocular2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineDopamine Agonistsgamma-Aminobutyric AcidGlycineReceptors, Dopamine D1amacrine cellbipolar cellglycineluminanceγ-aminobutyric acid (GABA)

Identifiers

PMID30726156
PMCPMC6485729
OpenAlexW2914730902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.